These genetic signatures support the theory that sporadic papillary thyroid cancers originate via mutations in the RET/RAS/BRAF/MAPK pathway, and could also predict tumors with these mutations with high accuracy. The gene discussed is RET; the disease is thyroid gland papillary carcinoma.